• No results found

University of Groningen Stapled peptides inhibitors Ali, Amina

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Stapled peptides inhibitors Ali, Amina"

Copied!
3
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Stapled peptides inhibitors

Ali, Amina

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date:

2019

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Ali, A. (2019). Stapled peptides inhibitors: A new window for target drug discovery. University of Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

173

(3)

174

Conferences

• ARC”16 Conference, 21-23 March 2016, Qatar National Convention Center, Qatar (Poster

presentation).

• 9

th

International Conference On Structural Biology, 18-20 September 2017, Zurich,

Switzerland. (Poster presentation).

• Pharmacy Day 2015, University of Groningen, (Oral presentation)

“Production of novel potent inhibitors of Human α-Amylases and α-Glucosidase: A novel

approach for the control of diabetes mellitus and obesity”.

• Pharmacy Day 2016, University of Groningen, (Oral presentation)

“Screening for MDM2 Small Molecule Inhibitors: Cancer Therapeutic Target”

• Pharmacy Day 2018, University of Groningen, (Oral presentation)

“Screening for MDM2-p53 Inhibitors: As Cancer Therapeutic Target”

Prizes

• First prize for the Best Oral Presentation, Pharmacy Day 2016, University of Groningen.

• First prize for the Best Poster Presentation, 9

th

International Conference On Structural

Biology, 18-20 September 2017, Zurich, Switzerland.

Referenties

GERELATEERDE DOCUMENTEN

iterative approximations gives a good tool to study networks not fitting in the exact methods mentioned above. This paper deals with an example. an iterative method to

Dutch-speaking children between 6 and 12 years old with autism spectrum disorder (ASD; n = 47), attention-deficit/hyperactivity disorder (ADHD; n = 36) or typical development (TD; n

Furthermore, we were able to solve three co-crystal structures of three stapled peptides in complex with a mutant MDM2 to reveal their binding mode to the hydrophobic cleft of

Additional two H-bonds were formed between the N atoms of Phe19 and Thr18 in the peptide helix and the carbonyl oxygen of Gln72 MDM2 residue (Figure 11a). The staple was

From these four compounds, the esterified enantiomer (R)-5a was active in cells, which was evidenced by the increase of p53 levels, the induction of expression of p53-target

Refolding of proteins derived from inclusion bodies is very promising as it can provide a reliable source of target proteins of high purity. However, inclusion body-based

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright

Matthew Groves, Assistance Professor in Drug Design Group- Groningen University, I am grateful for your tremendous support and for allowing me to grow as a research